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EDITORIAL
Choosing the Right Cross-sectional Imaging Technique:
Trading Image Quality for Radiation Risk
Radiographic techniques have greatly enhanced our ability
to determine Crohn’s disease (CD) extent and severity, and
identify complications such as strictures, abscesses, and fis-
tulae. They have provided insights into patients’ symptoms
and have helped us more appropriately direct therapy or
intervene with surgery. They are complementary to colono-
scopy and capsule endoscopy, adding significant informa-
tion about the bowel wall and involvement of adjacent tis-
sues. Due to its broad availability and high resolution,
computerized tomography (CT)-based imaging, especially
CT enterography (CTE), has become the most widely used
cross-sectional imaging technology for CD and has nearly
completely replaced small bowel follow-through at many
centers.1,2 CTE has become the ‘‘gold standard’’ to which
other imaging techniques are compared. Growing concern
and increased awareness about the risks associated with the
cumulative radiation dose secondary to repeated imaging,
particularly in young patients, have led to growing interest
in alternative imaging modalities.3 At the same time,
improved resolution of magnetic resonance imaging (MRI)-
based techniques, along with more effective methods to
deal with bowel motion and improved availability, have
driven a rapid increase in the use of MR enterography
(MRE) for CD imaging, even before the clinical usefulness
of MRE has been completely elucidated. The two articles
presented by Fiorino et al4 on the comparison of CTE and
MRE techniques for assessing disease activity and compli-
cations and Jensen et al5 on the interobserver and intermo-
dality agreement using CTE and MRE are part of mounting
academic research aimed at comparing the sensitivity and
diagnostic yield of MRE with CTE to validate the appro-
priateness of using the radiation-free MR technique to an-
swer important clinical questions in the management of
patients with CD.
The two articles add important information to our
understanding of MRE as a tool to assess disease severity
and identify complications of CD. Fiorino et al show that
CTE and MRE similarly identify disease localization, pres-
ence of wall thickening, bowel wall enhancement (with
MRE being slightly more sensitive for ileal wall enhance-
ment than CTE), presence of fistula, and mesenteric ade-
nopathy. There was a slightly higher sensitivity for MRE to
detect enteric strictures. Their study concluded that both
CTE and MRE are highly effective techniques in assessing
ileocolonic CD with broadly similar accuracy. Technical dif-
ferences in the performance of scans between institutions on
different continents raises questions as to the generalizability
of their conclusions. Even between US centers, differences
in protocols based on scanner manufacturer, oral and intra-
venous contrast agents, and other scan characteristics exist.
With respect to the current studies, differences in protocols
are relatively minor and do not limit the generalizability of
the authors’ conclusions. Indeed, the major difference
between scans performed in the US compared with non-US
centers appears to be cost, which is bewildering high in the
US compared to European and Asian institutions.
Jensen et al compared CTE and MRE with respect to
image quality in addition to disease evaluation, with assess-
ment of both interobserver and intermodality agreement for
four different reviewers. As noted in earlier studies, the
image quality was superior for CTE, which is not degraded
by motion artifact due to the fast acquisition time, espe-
cially with the use of multidetector CT (MDCT) technol-
ogy. For disease evaluation, the interobserver agreement
was high for CTE and moderate for MRE. On the other
hand the intermodality agreement was fair to substantial
depending on the reader. This suggests that the evaluation
of small bowel CD is both observer- and modality-depend-
ent. However, despite these differences both techniques
had comparable diagnostic yields. Therefore, given an
experienced radiologist, MRE offers an acceptable alterna-
tive to CTE despite the difference in image quality. While
interobserver agreement between radiologists at different
institutions would give a more complete perspective, this
study is an important step in validating this technique.
The relevant information in patients with suspected or
known CD includes the extent and distribution of disease,
presence or absence of stricture (with or without proximal
dilatation), assessment of disease activity, as well as detect-
ing the transmural/extraenteric complications (fistula and
abscess formation). The diagnostic imaging modalities avail-
able to the gastroenterologists are vast and include: optical
endoscopy (upper endoscopy, colonoscopy, video capsule
endoscopy, and advanced small bowel endoscopic techni-
ques) and radiologic techniques (plain radiography, small
bowel follow-through (SBFT), CTE, MRE, CT, and MR
enteroclysis, ultrasound, and positron emission tomography
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[PET] examination). Which imaging modality is ‘‘best’’ or
‘‘most informative’’ cannot be addressed simply, and in clin-
ical practice the information desired cannot usually be
derived from a single test. The optimal patient management
will incorporate clinical information with complementary in-
formation provided by several modalities.
Endoluminal direct visualization likely offers a supe-
rior and more detailed view of the mucosal changes that
may be more important in the early diagnosis of nonstric-
turing CD. In addition, endoscopic assessment is valuable
for obtaining biopsies and in assessing potent therapeutics
for evidence of mucosal healing. In the context of a clini-
cal trial colonoscopic assessment of disease activity may
include the use of the Crohn’s Disease Endoscopic Index
of Severity (CDEIS)6,7; no similarly validated scoring sys-
tem exists for cross-sectional imaging techniques. For small
bowel between the reach of the upper endoscope and the
colonoscope, capsule endoscopy and advanced endoscopic
applications such as double balloon enteroscopy are avail-
able. In several studies, capsule endoscopy has been shown
to be more sensitive than cross-sectional imaging for detect-
ing mucosal lesions, although it is argued that many of the
lesions are not clinically significant.8,9 Capsule retention and
secondary obstruction can complicate the use of capsule en-
doscopy in structuring CD.10,11 Ultrasound imaging of CD is
popular in Europe and is gaining interest in the US, but is
limited due to its operator-dependent nature and difficulty in
visualizing the entire length of the bowel.12 PET imaging is
highly sensitive to inflammation but is not widely used due
to expense and limited availability.13
CTE provides exquisite bowel images that lend
amazing insight into disease pathology. The introduction of
multidetector technology has allowed faster examinations,
leading to higher resolution of mucosal/bowel wall details.
The introduction of negative or neutral enteric oral contrast
allows for the evaluation of the mucosal details by achiev-
ing the needed bowel distension and creating the visual
contrast needed for the evaluation of the mucosal details
and enhancement patterns.14 Cross-sectional diagnostic
imaging can evaluate the extent of disease throughout the
small bowel and the large bowel in the same setting;
detects the presence of strictures with or without proximal
dilatation; as well as detects signs of penetrating disease
such as fistula and extraluminal abscess formation. CTE is
not as sensitive as endoscopic techniques for early changes
of CD that may primarily only include mucosal aphthous
ulceration, and therefore, the cross-sectional studies may be
more suitable for evaluation of patients with moderate to
severe disease or with stricturing/penetrating disease.8 Sup-
porting its usefulness in clinical practice, Higgins et al15
showed that CTE can add unique and unsuspected informa-
tion to the clinician assessment, especially in detecting
strictures, and that this additional information can change
the clinicians’ assessment of the likelihood of successful
medical therapy.
Cumulative radiation dosage from diagnostic imaging
has gained attention in the medical community and in the
lay press.3 Measurement of effective radiation doses in CT
is dependent on several factors including scanning tech-
nique and patient body habitus. A study by Jaffe et al16
found that the effective dose for abdominopelvic MDCT
was 16.1 mSv, which was up to five times higher than
SBFT. They emphasized that the long-term biologic impact
of this type of radiation exposure is not known. In addition,
studies suggest that cumulative exposure of lower-dose radi-
ation may have a similar effect as a single acute dose. More
recently, several changes were introduced to CT scanning
techniques that would allow the acquisition of ‘‘low-dose
CT’’ leading to decrease in the overall dose of radiation
delivered to the patient undergoing CT examination while
trying to maintain image quality. These changes include
lowering the tube current (mA) and voltage (kVp) settings
used in the CT scanner along with introduction of more
effective algorithms for image reconstruction that aim at
reducing the increased image noise typically associated with
these techniques.17
MRI of the gut has become more feasible with
improvement in the spatial resolution and speed of the MR
sequences which, in combination of the lack of ionizing
radiation and the better signal-to-noise ratio, can offer paral-
lel evaluation of both disease status assessment and evalua-
tion of the extraenteric complications.18–20 MRE was shown
to be of similar diagnostic value to CT in the evaluation of
acute complications of CD, providing an alternative to
image patients in the acute setting.21 Further, MR-based
techniques allow addition of sequences that may add novel
insight into the natural history of the disease such as mag-
netization transfer that specifically detects tissue stiffness
and correlates with tissue fibrosis.22 The two studies by Fior-
ino et al and Jensen et al further validate the adequacy of
MRE as a satisfactory examination that can replace CTE
examinations without the added risk of radiation.
The trade-off appears to be image quality for radia-
tion risk, with MRE having no radiation exposure but over-
all inferior image quality compared to CTE. Despite the
compromise in image quality, in experienced hands the
diagnostic yield may be equivalent. So how does a clini-
cian make the decision about the optimal technique on an
individual patient? Like many decisions we make in caring
for these challenging patients, we balance risks and bene-
fits, incorporating the literature, local expertise, and patient
factors, and then make the best decision possible. In many
cases this will mean choosing MRE over CTE in young
patients, saving CTE for difficult cases where defining pa-
thology using the technique with the optimal resolution is
essential. One strategy that is frequently employed at our
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institution is to use CTE for the initial exam, especially if
an abscess or fistulae is suspected, but use MRE for moni-
toring progress if follow-up scans are required. When eval-
uating patients with serious symptoms, common sense
should prevail to avoid the situation that can occur in preg-
nant patients with acute G1 symptoms where fear of diag-
nostic radiation can lead to delayed diagnosis and bad
patient outcomes. Finally, additional factors such as avail-
ability of MR, cost of the exam, and experience of the
radiologists need to be addressed before MRE is widely
utilized for imaging patients with CD.
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